Few recurrent oncogenic mutations have been observed in NB, with one exception being activating point mutations in the Anaplastic Lymphoma Kinase (ALK) receptor tyrosine kinase (RTK) encoded by ALK [19–24]. The gene discussed is ALK; the disease is neuroblastoma.